Cerity Partners LLC Increases Stock Position in Tenet Healthcare Corporation $THC

Cerity Partners LLC grew its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 8.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 156,141 shares of the company’s stock after buying an additional 12,060 shares during the quarter. Cerity Partners LLC’s holdings in Tenet Healthcare were worth $31,028,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in THC. Caption Management LLC bought a new stake in Tenet Healthcare during the 3rd quarter worth approximately $5,650,000. Hillsdale Investment Management Inc. raised its stake in Tenet Healthcare by 31.0% during the 3rd quarter. Hillsdale Investment Management Inc. now owns 22,800 shares of the company’s stock worth $4,629,000 after acquiring an additional 5,400 shares during the period. Eminence Capital LP bought a new stake in Tenet Healthcare during the 3rd quarter worth approximately $225,263,000. GenTrust LLC bought a new stake in Tenet Healthcare during the 3rd quarter worth approximately $895,000. Finally, Sirios Capital Management L P raised its stake in Tenet Healthcare by 100.9% during the 3rd quarter. Sirios Capital Management L P now owns 71,566 shares of the company’s stock worth $14,531,000 after acquiring an additional 35,947 shares during the period. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Trading Down 1.2%

Shares of THC opened at $164.44 on Thursday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21. The company has a 50 day simple moving average of $184.55 and a two-hundred day simple moving average of $200.25. The firm has a market cap of $14.16 billion, a P/E ratio of 8.55, a price-to-earnings-growth ratio of 1.37 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same period last year, the firm posted $4.36 EPS. The company’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, equities analysts expect that Tenet Healthcare Corporation will post 17.61 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Royal Bank Of Canada decreased their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research note on Friday, May 1st. UBS Group raised their target price on shares of Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Morgan Stanley set a $254.00 price objective on shares of Tenet Healthcare in a report on Friday, May 1st. Finally, Mizuho increased their price objective on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $244.16.

Insiders Place Their Bets

In related news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the transaction, the director directly owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the transaction, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.